ANTI-CD19-antistof med ADCC-funktion med forbedret glykosyleringsprofil

ANTI-CD19-antistof med ADCC-funktion med forbedret glykosyleringsprofil

The present invention relates to an anti-CD19 antibody having a variant Fc region having some specific amino acid modifications relative to a wild-type Fc region which confer one or several useful effector functions. The present invention relates in particular to chimeric, humanized or full human an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: VERMOT-DESROCHES, Claudine, SALLES, Gilles
Format: Patent
Sprache:dan
Schlagworte:
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator VERMOT-DESROCHES, Claudine
SALLES, Gilles
description The present invention relates to an anti-CD19 antibody having a variant Fc region having some specific amino acid modifications relative to a wild-type Fc region which confer one or several useful effector functions. The present invention relates in particular to chimeric, humanized or full human anti-CD19 antibodies comprising such a variant Fc region. It relates advantageously to antibodies with an interesting and valuable glycosylation profile, especially a low fucose level and/or a high oligomannose level and/or presence of sialic acid, high ADCC function and no CDC. The present invention also relates to the use of these antibodies in the treatment, prevention or management of diseases or disorders, such as cancer, especially a B-cell malignancy and auto-immune disease.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DK2596024TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DK2596024TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DK2596024TT33</originalsourceid><addsrcrecordid>eNrjZHB39Avx1HV2MbTUTcwrySwuyU9TyE1NUXB0cXbWTSvNyy7JzM8Di6TlFyWlphSlliik51Rm5xdX5qQWZealFxcU5adl5vAwsKYl5hSn8kJpbgZFN9cQZw_d1IL8-NTigsTk1LzUkngXbyNTSzMDI5OQEGNjYtQAAMXLM3Y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTI-CD19-antistof med ADCC-funktion med forbedret glykosyleringsprofil</title><source>esp@cenet</source><creator>VERMOT-DESROCHES, Claudine ; SALLES, Gilles</creator><creatorcontrib>VERMOT-DESROCHES, Claudine ; SALLES, Gilles</creatorcontrib><description>The present invention relates to an anti-CD19 antibody having a variant Fc region having some specific amino acid modifications relative to a wild-type Fc region which confer one or several useful effector functions. The present invention relates in particular to chimeric, humanized or full human anti-CD19 antibodies comprising such a variant Fc region. It relates advantageously to antibodies with an interesting and valuable glycosylation profile, especially a low fucose level and/or a high oligomannose level and/or presence of sialic acid, high ADCC function and no CDC. The present invention also relates to the use of these antibodies in the treatment, prevention or management of diseases or disorders, such as cancer, especially a B-cell malignancy and auto-immune disease.</description><language>dan</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190415&amp;DB=EPODOC&amp;CC=DK&amp;NR=2596024T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190415&amp;DB=EPODOC&amp;CC=DK&amp;NR=2596024T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VERMOT-DESROCHES, Claudine</creatorcontrib><creatorcontrib>SALLES, Gilles</creatorcontrib><title>ANTI-CD19-antistof med ADCC-funktion med forbedret glykosyleringsprofil</title><description>The present invention relates to an anti-CD19 antibody having a variant Fc region having some specific amino acid modifications relative to a wild-type Fc region which confer one or several useful effector functions. The present invention relates in particular to chimeric, humanized or full human anti-CD19 antibodies comprising such a variant Fc region. It relates advantageously to antibodies with an interesting and valuable glycosylation profile, especially a low fucose level and/or a high oligomannose level and/or presence of sialic acid, high ADCC function and no CDC. The present invention also relates to the use of these antibodies in the treatment, prevention or management of diseases or disorders, such as cancer, especially a B-cell malignancy and auto-immune disease.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHB39Avx1HV2MbTUTcwrySwuyU9TyE1NUXB0cXbWTSvNyy7JzM8Di6TlFyWlphSlliik51Rm5xdX5qQWZealFxcU5adl5vAwsKYl5hSn8kJpbgZFN9cQZw_d1IL8-NTigsTk1LzUkngXbyNTSzMDI5OQEGNjYtQAAMXLM3Y</recordid><startdate>20190415</startdate><enddate>20190415</enddate><creator>VERMOT-DESROCHES, Claudine</creator><creator>SALLES, Gilles</creator><scope>EVB</scope></search><sort><creationdate>20190415</creationdate><title>ANTI-CD19-antistof med ADCC-funktion med forbedret glykosyleringsprofil</title><author>VERMOT-DESROCHES, Claudine ; SALLES, Gilles</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DK2596024TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>dan</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>VERMOT-DESROCHES, Claudine</creatorcontrib><creatorcontrib>SALLES, Gilles</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VERMOT-DESROCHES, Claudine</au><au>SALLES, Gilles</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTI-CD19-antistof med ADCC-funktion med forbedret glykosyleringsprofil</title><date>2019-04-15</date><risdate>2019</risdate><abstract>The present invention relates to an anti-CD19 antibody having a variant Fc region having some specific amino acid modifications relative to a wild-type Fc region which confer one or several useful effector functions. The present invention relates in particular to chimeric, humanized or full human anti-CD19 antibodies comprising such a variant Fc region. It relates advantageously to antibodies with an interesting and valuable glycosylation profile, especially a low fucose level and/or a high oligomannose level and/or presence of sialic acid, high ADCC function and no CDC. The present invention also relates to the use of these antibodies in the treatment, prevention or management of diseases or disorders, such as cancer, especially a B-cell malignancy and auto-immune disease.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language dan
recordid cdi_epo_espacenet_DK2596024TT3
source esp@cenet
subjects CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
title ANTI-CD19-antistof med ADCC-funktion med forbedret glykosyleringsprofil
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T13%3A39%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VERMOT-DESROCHES,%20Claudine&rft.date=2019-04-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDK2596024TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true